ArticleImmunity, inflammation and disease2020

Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study.

Mohummad A Rahman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.